Tag: Task Force Report

ISPOR Publishes New Task Force Report on Constrained Optimization Methods

Research Methodology Can Help Identify Best Approaches to Achieve Optimal Health Outcomes for Patients Princeton, NJ—March 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new task force report, Constrained Optimization Methods in Health Services Research—An Introduction:

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , ,

“MAPPING STUDIES” IN COST-UTILITY ANALYSES: NEW RECOMMENDATIONS FROM ISPOR TASK FORCE

Guidance for the Consistent Application of Appropriate Analytical Methods   Princeton, NJ—February 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good

Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR RELEASES NEW TASK FORCE RECOMMENDATIONS FOR THE DEVELOPMENT OF CLINICIAN-REPORTED OUTCOME ASSESSMENTS

New Report Fills Long Standing Guidance Gap and Will Help Standardize ClinRO Assessments Princeton, NJ—February 13, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the

Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR TASK FORCE PROVIDES RECOMMENDATIONS ON THE COLLECTION OF HEALTH-STATE UTILITY DATA IN CLINICAL STUDIES

Five Areas of Guidance Enable Optimum Health-State Utility Measurement  Princeton, NJ—October 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Good Practices for Outcome Research—Measurement of Health-State Utility Values for Economic Models in Clinical Studies—has published

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: ,

ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL CONSIDERS MCDA AS A POSSIBLE NEW PARADIGM IN HEALTH CARE DECISION MAKING

Washington, DC—May 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 12—Multi-Criteria Decision Analysis: A New Paradigm in Health Care Decision Making? What Are the Current Status, Challenges, and Opportunities?—was held this afternoon

Posted in Announcements, ISPOR News & Press Tagged with: , , , , , , ,

ISPOR PUBLISHES TASK FORCE REPORT #2 ON MULTIPLE CRITERIA DECISION ANALYSIS

Second Report Published in March/April Issue of Value in Health Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report

Posted in Announcements, Brief Report, ISPOR News & Press, Value in Health Tagged with: , , , , , , , , , , , ,

ISPOR PUBLISHES NEW TASK FORCE REPORT ON MULTIPLE CRITERIA DECISION ANALYSIS

First of Two Reports Published in Value in Health Princeton, NJ—January 26, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,